Enliven Therapeutics, Inc.
ELVN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $101,732 | $119,437 | $101,705 | $124,117 |
| Short-Term Investments | $375,833 | $371,066 | $187,850 | $189,323 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,118 | $0 | $4,763 | $4,687 |
| Total Curr. Assets | $482,683 | $495,622 | $294,318 | $318,127 |
| Property Plant & Equip (Net) | $874 | $1,026 | $1,055 | $458 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7,318 | $7,239 | $7,197 | $7,175 |
| Total NC Assets | $8,192 | $8,265 | $8,252 | $7,633 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $490,875 | $503,887 | $302,570 | $325,760 |
| Liabilities | – | – | – | – |
| Payables | $1,429 | $2,351 | $1,562 | $1,342 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,040 | $63 | $2,157 | $4,813 |
| Total Curr. Liab. | $14,650 | $15,211 | $13,972 | $15,915 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $103 | $0 | $302 | $0 |
| Total NC Liab. | $103 | $204 | $302 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $387 | $580 | $365 | $0 |
| Total Liabilities | $14,753 | $15,415 | $14,274 | $15,915 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $59 | $59 | $49 | $49 |
| Retained Earnings | -$317,499 | -$297,351 | -$272,016 | -$243,472 |
| AOCI | $221 | -$177 | -$16 | $55 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $476,122 | $488,472 | $288,296 | $309,845 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $490,875 | $503,887 | $302,570 | $325,760 |
| Net Debt | -$101,732 | -$119,437 | -$101,705 | -$124,117 |